Epidermoidcarcinoma (alsoknown assquamous cellcarcinoma)of theparotidgland is moreprevalent among the elderly, asare otherheadand neck tumors. In most casesit isobservedeitherasa nodal metastasisofaprimary tumor that drains into theparotidareaor asa direct extension of a tumor that hasoriginated in the upperdermis. Primary epidermoid carcinomas arising directly from the parotid glandare extremely rare. Similarly, secondary invasion of theorbitalregionby a neighboring tumorismorecommon than primary epidermoid carcinoma of the orbit, which is also rare. In this article, we discuss the diagnosis and treatment of a rare case of epidermoid carcinoma simultaneously invading the parotidgland and the orbit.
primary parotid gland lesion.!" However, m ucoepidermoid carci nomas an d parotid metastases ofepide rmo id carcinomas are often confu sed with primary epide rmoid carcinomas of the parotid gland.
In a similar fashion , epidermoid carcinoma of the orbital region is usually observed as a secondary invasion of a tumor from a neighboring structure. Most patients with this tumor are of advanced age. 6 • 7 Early diagno sis and proper treatment are necessary because thi s tumor can cause blindness and life-threatening complications.Although rar ely, epidermoid carcinoma of the eyelid an d conjunctiva also can metastasize to the parotid lymph nodes.':'
Case report
An 89-year-old woman cam e to our clinic with a lump an d pain in front of her right ear of 1 year's duration. Upo n exami nation, a tender,im mo bile masswas detected in the right preaur icular regio n. It was hard in consistency and measur ed 4 x 3 em by palpat ion . The skin covering the mass was hyperemic, raising the suspic ion of tum or al infiltration .A solid ,fixed mass also was noted on the patient's right upper eyelid. Its margins were unidentifiable because of intense mucopurulent discharge and hyperemia. The patient's visual acuity could not be assessed because she could not op en th e affected eye. Her medical history included cataract surge ry on the same eye 5 years earlier,with un satisfactoryvision postoperatively. Her eyes had been examined and, apa rt from the vision difficulty on the operated side, evaluated as normal 1 year before she pre sented at our clinic.
Computed tom ography (CT) (figure 1,A ) and m agnetic reson ance imaging (MRI) (figure 1, B) revealed a 3 x 3-cm soft-tissuelesion on the right parotid gland,with margins in disti ng uishab le fro m the masse ter mu scle. The lesion showed periph eral contrast enhanceme nt and contained central cystic and necrotic areas.
Orbital CT showed an intact bulbus oculi and normal intraocular structures, but on the superior aspect of the right eyelid, a soft-tissue thickening of 1 em with sporadic nodularity and peripheral contrast enhancement was detected (figur e 2). Homogeneous contrast enhancement on the right lacrimal gland also was noted. There was no evidence of distant metastasis.
An eye examination performed under sedation revealed that the upper eyelid was infiltrated with a soft, fragile, and lobulated mass. The tumor was observed to be encasing the globe from the superior, inferior, and temporal aspects, as well as infiltrating the sclera and conjunctiva. The superior portion of the sclera was observed to be moderately fragile. With manual examination, the mobility of the globe was found to be limited. A fine-needle aspiration (FNA) biopsy of the parotid gland and incisional biopsies (as the tumor infiltrated Fi gure 2. Axial CT scan at the levelof the orbit shows Il l-cm sof ttissue thickeningon the superior aspect of the right eyelid.
Volume 87, Number 7 the skin) of the parotid gland and orbital region were taken.The FNAbiopsy of the parotid gland demonstrated poorly differentiated mucoepidermoid carcinoma and/ or undifferentiated carcinoma. Histochemical ana lysis of the obtained specimens indicated a malignant neoplastic growth with high mitotic activit y. The growth was noted to be forming cords and islets within the desmoplastic stroma, with hyperchromic, large nuclei and prominent nucleoli. There was also sparse singlecell hyperkeratinization. No histochemical staining was seen with per iodic acid-Schiff (PAS) or mucicarmine stains, which were performed to further elucidate the diagnosis.The morphologic and histochemical findings indicated a poorly differentiated epidermoid carcinoma (figure 3).
Exenteration of the right eye,a rad ical parotidectomy, and radical neck dissection were performed. Patho logic examination of the specimen revealed the apex of the exenteration and the surgical borders to be tumor-free; however, the examination showed that the tumor had invaded the facial nerve and vascular structures and that there was extensive tumor growth inside the orbit.
The patient underwent postoperative radiation therapy, which was directed at the surgical area. At 7 months postoperatively, a recurrent mass posterolateral to the sternocleidomastoid muscle was detected. The patient was hospitalized because of feeding difficulties and refused the offered chemotherapy.She died 2 months later as a result of multiple metastases.
Discussion
Paro tid tumors.Malignant parotid tumors represent 3 to 12% ofhead and neck malignancies. 8 Several researchers have noted th at the incidence of primary epidermoid www.entjournal.com • 395 carcinoma of the parotid is lower than that of metastatic epidermoid carcinoma.2,5,8-10Primary epidermoid carcinomas of th e parotid con stitute 0.1 to 1.8% of all parotid gland tumors.v'? while metastatic epidermoid carcinomas constitute 1.2 to 4.6 % ,309- 11 Lesions of the head and neck region have the potential to invade the parotid gland because of the complex lymphatic network of th e parotid and its rich interconnections with surrounding regions. The involvement of parotid nodes ,either by direct extension or by metastasis, is a serious problem. If the tumor extends out with the nodes into the gland, the prognosis is poor, even after radical sur gery. This is especially true of metastatic tumors, whose extension is rapid and which have high mortality and morbidity rates.'
Most tumors metastasizing to th e parotid nodes originate in the skin. Usually, ipsilateral tumors of the lateral and frontal scalp, face, eyelid, conjunctiva, mala r region , radi x of the nose, upper lip, anterior ear, external ear canal, or pre auricular or postauricular region metast asize to the parotid ."! Therefore, it is important to examine the skin, especially the haired skin, of a patient with a parotid mass.
Although primary epidermoid parotid tumors are rare, they can easily be confused with more common mucoepidermoid carcin omas or metastatic epidermoid carcinomas of the parotid." Batsakis et al reported 14 primary epidermoid carcinom a cases in their series of 580 parotid tumors." They later reviewed the clinical and histopathologic record s and reclassified the tumors. At th at time th ey stated that onl y 2 of the 14 cases had in fact been primary epidermoid carcinomas of th e parotid; 5 had been mucoepidermoid carcinomas, and 396 • www.entjournal.com 7 had been metastatic carcinomas originating from the oropharynx, oral cavity, and the skin of the lateral part of the face." In general, if an epidermoid carcinoma is found in the ipsilateral auricular region, on the scalp, on the eyelid, or on the skin of the postauricular region , the parotid lesion should be considered metastatic rather than primary.' :"
In repo rting on their series of 30 cases of epidermoid carcinoma of the parotid, Marks et al stated th at 3 of the cases resulted from direct invasion of the skin covering the parotid and 24 originated at other skin sites that drain into the parotid area.' They identified only 3 cases of primary epidermoid carcinoma of the parotid.
A combination of surgery and radiotherapy is advocated in metastatic involvement of the parotid gland. v" Because th ere are no established criteria to allow the surgeon to predict whether a cutaneous tumor will metastasize to the parotid,' the main issue in dealing with those kinds of tumors should be based on the tumor's potential for rapid, aggressive spread.
The type ofparotidectomy performed should be based on the disease's clinical involvem ent, as follows:
• If the involved lymph node is mobile and located superficially and the tumor is confined to the node's bo rders, a superficial parotidectomy, sparing the facial nerve, is usuall y performed.
• If neural and diffuse glandular involvement is present, then radical excision with facial nerve sacrifice is performed.
• If clinical and/or met astatic disease extends deep into the facial nerve, radical total parotidectomy is performed. A study by Lee et al demonstrated that patients with metastases to the parotid gland who presented a short time (mean: 4 months) after excision ofa primary tumor tended to have lymph node invo lvement that co uld be treated with superficial parotidectomy.' Patients with a longer delay (mean: 8 months) tended to have more diffuse involvement of the parotid gland and required total parotidectomy. ' Marks et al reported that, in their series, all patients with metastases to the parotid gland presented within 24 months after excision of their skin lesions.' Like Lee et al, these researchers found that those patients who presented with metastases to the parotid 8 months or more after treatment for the primary skin cancer tended to have more advanced dise ase. Lee et al also noted that the risk of metastasis from skin cancer to the parotid decreases overtime but remains significant until about 19 months.' Marks et al suggested that patients be follow ed monthly for the first 2 years after skin cancer treatment and closely thereafter.' It also has been stated that an overall incidence of 1.5% of metastases of skin cancer to the parotid nodes is too low to advocate superficial parotidectomy in all patients.' Even if that is tru e, these patients need to be followed very closely after excision of their skin cancers.
ENT-Ear
Orbital tum ors. It should be noted, in light of our patient's having epidermoid carcinoma involving both the parotid gland and the orbital region, that although many epidermoid tumors originating in the pinna and metastasizing to the parotid gland have been reported, the incidence of orbital tumors metastasizing to th e parotid gland cannot be determined because this is such a rare occurrence. However, as we noted earlier, epidermoid carcinomas of the eyelid do have a tendency to metastasize to the parotid gland.':'
Orbital tumors can be primary, secondary, or metastatic.An indurated, palpable periocular mass, an ulcerated lesion, and ocular motility disturbances are the most frequent findings at initial examination." Primary epidermoid carcinoma of the orbit results from SCC of the lacrim al gland, wh ich is a rare entity. SCCs of the lu ng and salivary glands occasionally me tastasize to the Volume 87, Number 7 orbit. In fact, most orbital SCCs are secondary. Secondary orbital tumors result from direct tumor extension from adj acent structures, such as the eyelid , conjunctiva, globe, intracranial cavit y, or paranasal sinuses. In Western countries, most secondary SCCs extend to the orbit from the paranasal sinuses or eyelid skin; in tropical countries, orbital involvement of conjunctival epidermoid tumors is more common. Large or recurrent tumors in the periocular region should be treated aggressively at the early stages of the disease, to prevent vision loss secondary to orbital invasion and intracranial spread. Once a diagnosis of epidermoid carcinoma of the conjunctiva or the eyelid has been made, wide surgicalexcision ofthe tumor,using frozen-section control to ensure tumor-free margins, should be performed. If orbital extension has occurred, exenteration is usually required, as well as removal of any involved bone or sinuses, because of the infiltrative nature of the tumor. Lymph node dissection is used for regional lymph node metastases. In patients with advanced metastases, such as asymptomatic microscopic metastases or clinical perineural involvement, adjuvant radiotherapy may be required. '!
Conclusion
In our case, both orbital and parotid invo lvement occurred.The patient presented with complaints of swelling and extreme pa in in her right preauricular area and rig ht www.entjournal.com • 39 7 eye, as well as mucopurulent discharge from the eye.She was unable to open her eye and was experiencing vision difficulties . The tumor was suspected to be caused by chronic inflammation secondary to the patient's earlier cataract surgery. She had experienced vision problems ever since that surgery, even though an eye examination she underwent 1year before presenting to us was normal. As the definitive histopathologic discrimination could not be made as to whether the tumor in her parotid gland was primary or metastatic, we speculated that the coexistence of an ipsilateral epidermoid carcinoma ofthe parotid gland should raise the possibility of an epidermoid tumor stemm ing from the eyelid or conjunctiva, which drains into this region's lymph nodes.
Despite postoperative radiotherapy, our patient's disease progressed rap idly,and recurrence was dete cted 7 months postoperatively. She refused further th erapy and died 2 months later.
The occurrence of an epidermoid carcinoma of the parotid gland should alert the physician to the possibility 398· www.entjournal.com that the tumor stem s from an epidermoid carcinoma ofa neighboring structure,such as the eyelid or conjunctiva. Epidermoid carcinoma of the parotid gland has a more aggressive course than other epidermoid carcinomas of th e head and neck. The prognosis depends on whether the tumor is confined to th e intraglandular node or has spread to the parenchyma. The prognosis is relatively good when the former occurs but is extremely poor when the latter is th e case, even despite radical sur gery.' Therefore, it is crucial to examine other po ssible primary focuses that might be the source of the tumor when a patient pre sents with a parotid mass .
